Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1979 Aug;64(2):351–360. doi: 10.1172/JCI109469

Selective Depression of the Xenogeneic Cell-Mediated Lympholysis in Systemic Lupus Erythematosus

B Charpentier 1, C Carnaud 1, J F Bach 1
PMCID: PMC372126  PMID: 110833

Abstract

The immunological responsiveness of a panel of 17 patients with systemic lupus erythematosus (SLE) was studied in an in vitro model of xenogeneic sensitization against mouse lymphoid cells. Generation of cytotoxic thymus-derived (T) cells evaluated by a chromium release assay against labeled target cells was found to be drastically impaired in these lupus patients. Such depression was independent of drug therapy at the time of the study, clinical status, and other immunological parameters such as antibodies against native DNA, complement levels, cryoglobulinemia, circulating immune complexes, or T- and bone marrow-derived (B)-cell numbers. In contrast to the cytotoxic response, the proliferative responses to phytohemagglutinin, to allogeneic lymphocytes, and to xenogeneic lymphocytes were not significantly different from those of normal individuals. The latter response was shown to be H-2 restricted with the primed lymphocyte test. These results suggest the presence of a selective defect in the generation or in the expression of killer cells rather than a deficiency in antigen recognition by T cells. The role of serum factor(s) was examined by educating the lymphocytes of normal subjects in the presence of serum from SLE patients. Such manipulation affected both the generation of killer cells and the proliferative response. Finally our observations indicate that depression of cell-mediated immunity in SLE patients may be associated with several mechanisms including a cellular one, specifically affecting the generation of killer T cells, and a humoral one possibly as a result of antilymphocytic antibodies and(or) immune complexes.

Full text

PDF
351

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allison A. C., Denman A. M., Barnes R. D. Cooperating and controlling functions of thymus-derived lymphocytes in relation to autoimmunity. Lancet. 1971 Jul 17;2(7716):135–140. doi: 10.1016/s0140-6736(71)92306-3. [DOI] [PubMed] [Google Scholar]
  2. Andersson L. C., Häyry P., Bach M. A., Bach J. F. Differences in the effects of adult thymectomy on T-cell mediated responses in vitro. Nature. 1974 Nov 15;252(5480):252–254. doi: 10.1038/252252b0. [DOI] [PubMed] [Google Scholar]
  3. Bach J. F. Evaluation of T-cells and thymic serum factors in man using the rosette technique. Transplant Rev. 1973;16(0):196–217. doi: 10.1111/j.1600-065x.1973.tb00121.x. [DOI] [PubMed] [Google Scholar]
  4. Bach M. A. Lymphocyte-mediated cytotoxicity: effects of ageing, adult thymectomy and thymic factor. J Immunol. 1977 Aug;119(2):641–647. [PubMed] [Google Scholar]
  5. Bianco C., Patrick R., Nussenzweig V. A population of lymphocytes bearing a membrane receptor for antigen-antibody-complement complexes. I. Separation and characterization. J Exp Med. 1970 Oct 1;132(4):702–720. doi: 10.1084/jem.132.4.702. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Block S. R., Gibbs C. B., Stevens M. B., Shulman L. E. Delayed hypersensitivity in systemic lupus erythematosus. Ann Rheum Dis. 1968 Jul;27(4):311–318. doi: 10.1136/ard.27.4.311. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Bresnihan B., Jasin H. E. Suppressor function of peripheral blood mononuclear cells in normal individuals and in patients with systemic lupus erythematosus. J Clin Invest. 1977 Jan;59(1):106–116. doi: 10.1172/JCI108607. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Cantor H., McVay-Boudreau L., Hugenberger J., Naidorf K., Shen F. W., Gershon R. K. Immunoregulatory circuits among T-cell sets. II. Physiologic role of feedback inhibition in vivo: absence in NZB mice. J Exp Med. 1978 Apr 1;147(4):1116–1125. doi: 10.1084/jem.147.4.1116. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Carnaud C., Fadaï-Ghotbi M., Lesavre P., Bach J. F. Education of human lymphocytes against mouse cells: specific recognition of H-2 antigens. Eur J Immunol. 1977 Feb;7(2):81–85. doi: 10.1002/eji.1830070206. [DOI] [PubMed] [Google Scholar]
  10. Cochrane C. G., Koffler D. Immune complex disease in experimental animals and man. Adv Immunol. 1973;16(0):185–264. doi: 10.1016/s0065-2776(08)60298-9. [DOI] [PubMed] [Google Scholar]
  11. Digeon M., Laver M., Riza J., Bach J. F. Detection of circulating immune complexes in human sera by simplified assays with polyethylene glycol. J Immunol Methods. 1977;16(2):165–183. doi: 10.1016/0022-1759(77)90051-5. [DOI] [PubMed] [Google Scholar]
  12. Foad B. S., Khullar S., Freimer E. H., Kirsner A. B., Sheon R. P. Cell-mediated immunity in systemic lupus erythematosus: alterations with advancing age. J Lab Clin Med. 1975 Jan;85(1):132–139. [PubMed] [Google Scholar]
  13. Gerber N. L., Hardin J. A., Chused T. M., Steinberg A. D. Loss with age in NZB-W mice of thymic suppressor cells in the graft-vs-host reaction. J Immunol. 1974 Nov;113(5):1618–1625. [PubMed] [Google Scholar]
  14. Goldman J. A., Litwin A., Adams L. E., Krueger R. C., Hess E. V. Cellular immunity to nuclear antigens in systemic lupus erythematosus. J Clin Invest. 1972 Oct;51(10):2669–2677. doi: 10.1172/JCI107085. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Hahn B. H., Bagby K. K., Osterland C. K. Abnormalities of delayed hypersensitivity in systemic lupus erythematosus. Am J Med. 1973 Jul;55(1):25–31. doi: 10.1016/0002-9343(73)90146-0. [DOI] [PubMed] [Google Scholar]
  16. Harbeck R. J., Bardana E. J., Kohler P. F., Carr R. I. DNA:anti-DNA complexes: their detection in systemic lupus erythematosus sera. J Clin Invest. 1973 Apr;52(4):789–795. doi: 10.1172/JCI107242. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Horwitz D. A., Cousar J. B. A relationship between impaired cellular immunity humoral suppression of lymphocyte function and severity of systemic lupus erythematosus. Am J Med. 1975 Jun;58(6):829–835. doi: 10.1016/0002-9343(75)90639-7. [DOI] [PubMed] [Google Scholar]
  18. Horwitz D. A. Impaired delayed hypersensitivity in systemic lupus erythematosus. Arthritis Rheum. 1972 Jul-Aug;15(4):353–359. doi: 10.1002/art.1780150406. [DOI] [PubMed] [Google Scholar]
  19. KUNKEL H. G., TAN E. M. AUTOANTIBODIES AND DISEASE. Adv Immunol. 1964;27:351–395. doi: 10.1016/s0065-2776(08)60711-7. [DOI] [PubMed] [Google Scholar]
  20. Krishnan C., Kaplan M. H. Immunopathologic studies of systemic lupus erythematosus. II. Antinuclear reaction of gamma-globulin eluted from homogenates and isolated glomeruli of kidneys from patients with lupus nephritis. J Clin Invest. 1967 Apr;46(4):569–579. doi: 10.1172/JCI105558. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Leclerc J. C., Plater C., Fridman W. H. The role of the Fc receptor (FcR) of thymus-derived lymphocytes. I. Presence of FcR on cytotoxic lymphocytes and absence of direct role in cytotoxicity. Eur J Immunol. 1977 Aug;7(8):543–548. doi: 10.1002/eji.1830070810. [DOI] [PubMed] [Google Scholar]
  22. Lies R. B., Messner R. P., Williams R. C., Jr Relative T-cell specificity of lymphocytotoxins from patients with systemic lupus erythematosus. Arthritis Rheum. 1973 May-Jun;16(3):369–375. doi: 10.1002/art.1780160312. [DOI] [PubMed] [Google Scholar]
  23. Lindahl K. F., Bach F. H. Genetic and cellular aspects of xenogeneic mixed leukocyte culture reaction. J Exp Med. 1976 Aug 1;144(2):305–318. doi: 10.1084/jem.144.2.305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Lindahl K. F., Bach F. H. Human lymphocytes recognise mouse alloantigens. Nature. 1975 Apr 17;254(5501):607–609. doi: 10.1038/254607a0. [DOI] [PubMed] [Google Scholar]
  25. Malavé I., Layrisse Z., Layrisse M. Dose-dependent hyporreactivity to phytohemagglutinin in systemic lupus erythematosus. Cell Immunol. 1975 Feb;15(2):231–236. doi: 10.1016/0008-8749(75)90001-5. [DOI] [PubMed] [Google Scholar]
  26. Messner R. P., Lindström F. D., Williams R. C., Jr Peripheral blood lymphocyte cell surface markers during the course of systemic lupus erythematosus. J Clin Invest. 1973 Dec;52(12):3046–3056. doi: 10.1172/JCI107503. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Mittal K. K., Rossen R. D., Sharp J. T., Lidsky M. D., Butler W. T. Lymphocyte cytotoxic antibodies in systemic lupus erythematosus. Nature. 1970 Mar 28;225(5239):1255–1256. doi: 10.1038/2251255a0. [DOI] [PubMed] [Google Scholar]
  28. Nies K. M., Brown J. C., Dubois E. L., Quismorio F. P., Friou G. J., Terasaki P. I. Histocompatibility (HL-A) antigens and lymphocytotoxic antibodies in systemic lupus erythematosus (SLE). Arthritis Rheum. 1974 Jul-Aug;17(4):397–402. doi: 10.1002/art.1780170409. [DOI] [PubMed] [Google Scholar]
  29. Parker L. M., Chused T. M., Steinberg A. D. Immunofluorescence studies on thymocytotoxic antibody from New Zealand Black mice. J Immunol. 1974 Jan;112(1):285–292. [PubMed] [Google Scholar]
  30. Patrucco A., Rothfield N. F., Hirschhorn K. The response of cultured lymphocytes from patients with systemic lupus erythematosus to DNA. Arthritis Rheum. 1967 Feb;10(1):32–37. doi: 10.1002/art.1780100105. [DOI] [PubMed] [Google Scholar]
  31. Paty J. G., Jr, Sienknecht C. W., Townes A. S., Hanissian A. S., Miller J. B., Masi A. T. Impaired cell-mediated immunity in systemic lupus erythematosus (SLE). A controlled study of 23 untreated patients. Am J Med. 1975 Dec;59(6):769–779. doi: 10.1016/0002-9343(75)90462-3. [DOI] [PubMed] [Google Scholar]
  32. Pincus T., Schur P. H., Rose J. A., Decker J. L., Talal N. Measurement of serum DNA-binding activity in systemic lupus erythematosus. N Engl J Med. 1969 Sep 25;281(13):701–705. doi: 10.1056/NEJM196909252811304. [DOI] [PubMed] [Google Scholar]
  33. Scheinberg M. A., Cathcart E. S. B cell and T cell lymphopenia in systemic lupus erythematosus. Cell Immunol. 1974 May;12(2):309–314. doi: 10.1016/0008-8749(74)90083-5. [DOI] [PubMed] [Google Scholar]
  34. Senyk G., Hadley W. K., Attias M. R., Talal N. Cellular immunity in systemic lupus erythematosus. Arthritis Rheum. 1974 Sep-Oct;17(5):553–562. doi: 10.1002/art.1780170509. [DOI] [PubMed] [Google Scholar]
  35. Shirai T., Mellors R. C. Natural thymocytotoxic autoantibody and reactive antigen in New Zealand black and other mice. Proc Natl Acad Sci U S A. 1971 Jul;68(7):1412–1415. doi: 10.1073/pnas.68.7.1412. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Stastny P., Ziff M. Antibodies against cell membrane constituents in systemic lupus erythematosus and related diseases. I. Cytotoxic effect of serum from patients with systemic lupus erythematosus (SLE) for allogeneic and for autologous lymphocytes. Clin Exp Immunol. 1971 Apr;8(4):543–550. [PMC free article] [PubMed] [Google Scholar]
  37. Stout R. D., Waksal S. D., Herzenberg L. A. The Fc receptor on thymus-derived lymphocytes. III. Mixed lymphocyte reactivity and cell-mediated lympholytic activity of Fc- and Fc+ T lymphocytes. J Exp Med. 1976 Jul 1;144(1):54–68. doi: 10.1084/jem.144.1.54. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Suciu-Foca N., Buda J. A., Thiem T., Reemtsma K. Impaired responsiveness of lymphocytes in patients with systemic lupus erythematosus. Clin Exp Immunol. 1974 Nov;18(3):295–301. [PMC free article] [PubMed] [Google Scholar]
  39. Talal N. Immunologic and viral factors in the pathogenesis of systemic lupus erythematosus. Arthritis Rheum. 1970 Nov-Dec;13(6):887–894. doi: 10.1002/art.1780130620. [DOI] [PubMed] [Google Scholar]
  40. Talal N., Steinberg A. D. The pathogenesis of autoimmunity in New Zealand black mice. Curr Top Microbiol Immunol. 1974;64(0):79–103. doi: 10.1007/978-3-642-65848-8_3. [DOI] [PubMed] [Google Scholar]
  41. Terasaki P. I., Mottironi V. D., Barnett E. V. Cytotoxins in disease. Autocytotoxins in lupus. N Engl J Med. 1970 Oct 1;283(14):724–728. doi: 10.1056/NEJM197010012831403. [DOI] [PubMed] [Google Scholar]
  42. Toh B. H., Roberts-Thomson I. C., Mathews J. D., Whittingham S., Mackay I. R. Depression of cell-mediated immunity in old age and the immunopathic diseases, lupus erythematosus, chronic hepatitis and rheumatoid arthritis. Clin Exp Immunol. 1973 Jun;14(2):193–202. [PMC free article] [PubMed] [Google Scholar]
  43. Utsinger P. D. Lymphocyte responsiveness in systemic lupus erythematosus. Arthritis Rheum. 1976 Jan-Feb;19(1):88–92. doi: 10.1002/art.1780190115. [DOI] [PubMed] [Google Scholar]
  44. Utsinger P. D., Yount W. J. Phytohemagglutinin response in systemic lupus erythematosus. Reconstitution experiments using highly purified lymphocyte subpopulations and monocytes. J Clin Invest. 1977 Sep;60(3):626–638. doi: 10.1172/JCI108814. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Widmer M. B., Bach F. H. Allogeneic and xenogeneic response in mixed leukocyte cultures. J Exp Med. 1972 May 1;135(5):1204–1208. doi: 10.1084/jem.135.5.1204. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Williams R. C., Jr, DeBoard J. R., Mellbye O. J., Messner R. P., Lindström F. D. Studies of T- and B-lymphocytes in patients with connective tissue diseases. J Clin Invest. 1973 Feb;52(2):283–295. doi: 10.1172/JCI107184. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Williams R. C., Jr, Lies R. B., Messner R. P. Inhibition of mixed leukocyte culture responses by serum and gamma-globulin fractions from certain patients with connective tissue disorders. Arthritis Rheum. 1973 Sep-Oct;16(5):597–605. doi: 10.1002/art.1780160504. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES